Practice
Featured experience
PSG VI $6 billion fundraise and $2 billion continuation fund
We advised PSG on the fundraise for PSG VI and a multi-asset GP-led secondary continuation fund transaction
J.F. Lehman closes $2.2 billion Fund VI
We advised J.F. Lehman on the fundraise and related matters
GHK Capital Partners completes $870 million fundraise for its second fund
We advised GHK Capital Partners on the fundraise and related matters for GHK Fund II
Grayscale Bitcoin Trust approved as world’s largest bitcoin ETF
We advised Grayscale in the yearslong effort to secure SEC approval for the NYSE Arca listing
Royal Bank of Scotland Group $1.5 billion convertible Tier 1 notes offering
Davis Polk advised The Royal Bank of Scotland Group plc, a public limited company incorporated under the laws of Scotland,…
CryoLife $100 million convertible senior notes offering
Davis Polk advised the initial purchaser in connection with a Rule 144A offering by CryoLife, Inc. of $100 million aggregate…
Genetron Holdings $256 million IPO
Davis Polk advised Genetron Holdings Limited on its SEC-registered initial public offering of 16,000,000 American Depositary…
Uniti Group $250 million at-the-market stock offering
Davis Polk advised Uniti Group Inc., as issuer, in connection with a new SEC-registered at-the-market offering program by…
Equinix $2.6 billion senior notes offering
Davis Polk advised Equinix, Inc. on an SEC-registered offering of $2.6 billion aggregate principal amount of senior notes…
NetApp $2 billion notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by NetApp,…
BBVA €1.1 billion asset-backed notes offering
Davis Polk advised Banco Bilbao Vizcaya Argentaria, S.A. on the offering of asset-backed notes with an aggregate face value…
Royalty Pharma $2.5 billion IPO
Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering…
Credicorp $500 million notes offering
Davis Polk advised Credicorp Ltd. in connection with its $500 million offering of 2.750% notes due 2025, which were issued…
Aptiv $2.2 billion ordinary share and mandatory convertible preferred offerings
Davis Polk advised Aptiv PLC in connection with a $1.1 billion SEC-registered offering of 15,149,519 ordinary shares (which…